Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 845, Issue -, Pages 65-73Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2018.12.027
Keywords
3,4-Dihydroxyphenylacetaldehyde; alpha-Synuclein aggregation; Schiff base adducts
Categories
Funding
- NIH, USA [P41-GM103422, P60-DK-20579, P30-DK-56341]
- TEVA
- Veterans Administration Merit Review
Ask authors/readers for more resources
3,4-Dihydroxyphenylacetaldehyde (DOPAL), the monoamine oxidase (MAO) metabolite of dopamine, plays a role in pathogenesis of Parkinson disease, inducing a-synuclein aggregation. DOPAL generates discrete alpha-synuclein aggregates. Inhibiting this aggregation could provide therapy for slowing Parkinson disease progression. Primary and secondary amines form adducts with aldehydes. Rasagiline and aminoindan contain these amine groups. DOPAL-induced alpha-synuclein aggregates were resolved in the presence and absence of rasagiline or aminoindan using quantitative Western blotting. DOPAL levels in incubation mixtures, containing increased rasagiline or aminoindan concentrations, were determined by high pressure liquid chromatography (HPLC). Schiff base adducts between DOPAL and rasagiline or aminoindan were determined using mass spectrometry. A neuroprotective effect of rasagiline and aminoindan against DOPAL-induced toxicity was demonstrated using PC-12 cells. Rasagiline and aminoindan significantly reduced aggregation of alpha-synuclein of all sizes in test tube and PC-12 cells experiments. Dimethylaminoindan did not reduce aggregation. DOPAL levels in incubation mixtures were reduced with increasing rasagiline or aminoindan concentrations but not with dimethylaminoindan. Schiff base adducts between DOPAL and either rasagiline or aminoindan were demonstrated by mass spectrometry. A neuroprotective effect against DOPAL-induced toxicity in PC-12 cells was demonstrated for both rasagiline and aminoindan. Inhibiting DOPAL-induced alpha-synuclein aggregation through amine adducts provides a therapeutic approach for slowing Parkinson disease progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available